Aurovir Pharma GmbH is a startup based in Austria.
Aurovir Pharma GmbH develops gold-ion (aurothioglucose) based inhaled therapies for respiratory diseases, focusing on antiviral and anti-inflammatory treatments for viral pulmonary infections and other lung disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.